Praxis Precision Medicines (PRAX) Other financing activities (2020 - 2026)

Praxis Precision Medicines' Other financing activities history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Other financing activities rose 99.82% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $13.8 million, a 353.54% increase from a year earlier, with the FY2025 full-year figure at $13.3 million, up 404.14% from the prior year.
• Other financing activities declined to $1.1 million in Q1 2026 per PRAX's latest filing, from $11.6 million in the prior quarter.
• Across five years, Other financing activities topped out at $11.6 million in Q4 2025 and bottomed at $1000.0 in Q3 2023.
• The 5-year median for Other financing activities is $315000.0 (2024), against an average of $1.1 million.
• Across the five-year window, Other financing activities plunged 99.76% in 2023 and soared 20000.0% in 2024, its largest moves.
• Year by year, Other financing activities stood at $163000.0 in 2022, then tumbled by 34.97% to $106000.0 in 2023, then surged by 1762.26% to $2.0 million in 2024, then jumped by 488.25% to $11.6 million in 2025, then slumped by 90.36% to $1.1 million in 2026.
• Per Business Quant, the three latest PRAX Other financing activities figures stand at $1.1 million (Q1 2026), $11.6 million (Q4 2025), and $808000.0 (Q3 2025).